These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 33240453)

  • 21. Fractional Exhaled Nitric Oxide Testing for the Diagnosis and Management of Asthma: a Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2024; 24(5):1-225. PubMed ID: 39329005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internet-Delivered Cognitive Behavioural Therapy for Post-traumatic Stress Disorder or Acute Stress Disorder: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(9):1-120. PubMed ID: 34527087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis.
    Peinemann F; Harari M; Peternel S; Chan T; Chan D; Labeit AM; Gambichler T
    Cochrane Database Syst Rev; 2020 May; 5(5):CD011941. PubMed ID: 32368795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Level 2 Polysomnography for the Diagnosis of Sleep Disorders: A Health Technology Assessment.
    Ontario Health
    Ont Health Technol Assess Ser; 2024; 24(7):1-157. PubMed ID: 39372311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal Pessaries for Pelvic Organ Prolapse or Stress Urinary Incontinence: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(3):1-155. PubMed ID: 34055111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review of UV-based therapy for psoriasis.
    Almutawa F; Alnomair N; Wang Y; Hamzavi I; Lim HW
    Am J Clin Dermatol; 2013 Apr; 14(2):87-109. PubMed ID: 23572293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(4):1-232. PubMed ID: 34055112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(4):1-141. PubMed ID: 29805721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-Free Circulating Tumour DNA Blood Testing to Detect
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(5):1-176. PubMed ID: 32206157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Testing for Thyroid Nodules of Indeterminate Cytology: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(2):1-111. PubMed ID: 35591972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-surgical Nasal Decolonization of
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(4):1-165. PubMed ID: 36160757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
    J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(3):1-223. PubMed ID: 30847009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2019; 19(8):1-108. PubMed ID: 31942227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(1):1-142. PubMed ID: 34055109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.